Effects of low-dose dopexamine on splanchnic oxygenation during major abdominal surgery

Crit Care Med. 1999 Nov;27(11):2389-93. doi: 10.1097/00003246-199911000-00011.

Abstract

Objective: To study the influence of low-dose dopexamine on splanchnic oxygenation during major abdominal surgery.

Design: Prospective, randomized, placebo-controlled study.

Setting: University hospital.

Patients: Eighteen adult patients undergoing elective major abdominal surgery.

Interventions: The patients received either dopexamine at 1 microg/kg/min (group A, n = 9) or 0.90% saline as control (group B, n = 9).

Measurements and results: To assess the splanchnic oxygenation, intestinal tissue PO2 (PtissO2) and gastric intramucosal Pco2 (PmucCO2) were measured, and the PCO2 gap (PmucCO2 - PaCO2) was calculated at baseline (T1) and after an infusion period of 60 mins (T2). There was no difference between the groups in the global oxygen transport parameters. Low-dose dopexamine increases PtissO2 on the serosal side of the small bowel (deltaPtissO2, 17+/-24 mm Hg in group A vs. -5+/-10 in group B). The changes in PtissO2 at the serosal side of the colon after dopexamine demonstrated a nonsignificant increase (deltaPtissO2, 7+/-11 mm Hg in group A vs. -11+/-23 mm Hg in group B). In both groups, the Pco2 gap (group A, 6+/-7 mm Hg [T1] and 5+/-6 mm Hg [T2], vs. group B, 9+/-10 mm Hg [T1] and 12+/-10 mm Hg [T2]) remained unchanged compared with the baseline.

Conclusion: It is concluded that low-dose dopexamine improves PtissO2 at the serosal side of the gut, preferably at the small bowel. However, low-dose dopexamine did not improve gastric PmucCO2.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Abdomen / surgery*
  • Adrenergic beta-Agonists / administration & dosage*
  • Adult
  • Aged
  • Blood Flow Velocity / drug effects
  • Blood Pressure / drug effects
  • Digestive System Surgical Procedures*
  • Dopamine / administration & dosage
  • Dopamine / analogs & derivatives*
  • Heart Rate / drug effects
  • Humans
  • Infusions, Intravenous
  • Intestinal Mucosa / blood supply
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism
  • Intraoperative Period
  • Middle Aged
  • Oxygen Consumption / drug effects*
  • Prospective Studies
  • Splanchnic Circulation / drug effects
  • Spleen / blood supply
  • Spleen / metabolism*

Substances

  • Adrenergic beta-Agonists
  • dopexamine
  • Dopamine